Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04496921

Vitamin K Supplementation to Reduce Deficiencies in Adults With Cystic Fibrosis

Vitamin K Supplementation to Reduce Deficiencies in Adults With Cystic Fibrosis : A Pilot Study

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Institut de Recherches Cliniques de Montreal · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cystic fibrosis (CF) patients are at risk for vitamin K deficiencies. Supplementation for fat-soluble vitamins A, D, and E is well established, but in CF, there is little data for vitamin K concerning the optimal dose and frequency of supplementation. Beyond its known role in coagulation, research has highlighted the role of vitamin K for bone health and the control of blood sugar levels. However, after pulmonary complications, the risk of diabetes and bone diseases are two important and frequent complications of CF. Patients with CF being at risk of vitamin K deficiencies, this vitamin could play a role in these complications.

Detailed description

The investigators propose a pilot study (carried out to assess its feasibility on a larger scale) to evaluate if a supplement of vitamin K improves vitamin K serum levels in CF patients by comparing: * Group A: a vitamin K supplement of 2mg, every day for 6 months * Group B: a vitamin K supplement of 7mg, twice a week for 6 months

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin K supplementation, dose #1Vitamin K supplement : 2mg, once a day, for 6 months. Complete biochemical profile, weight and size (body mass index), drugs list, pulmonary function by spirometry (FEV, etc.). Food frequency questionnaire.
DIETARY_SUPPLEMENTVitamin K supplementation, dose #2Vitamin K supplement : 7mg, twice a week, for 6 months. Complete biochemical profile, weight and size (body mass index), drugs list, pulmonary function by spirometry (FEV, etc.). Food frequency questionnaire.

Timeline

Start date
2020-08-10
Primary completion
2021-08-16
Completion
2021-08-16
First posted
2020-08-04
Last updated
2021-08-20

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT04496921. Inclusion in this directory is not an endorsement.